Mutual exclusivity of ARID1A and KRAS (all and specifically at residues G12 and G13) mutations in the colorectal adenocarcinoma patient cohort from the TCGA PanCancer Atlas (b). Here, ARID1A is linked to colorectal adenocarcinoma.